Impact Of Sacral Neuromodulation On Urine Markers For Interstitial Cystitis (IC)

Kenneth Peters, MD11 enrolled

Overview

Urine will be collected and sent to the University of Maryland. Urines will be analyzed for urine markers.

Urine will be collected and flash frozen in liquid nitrogen then placed in a -70 C freezer. All urine will be collected and stored until the final follow-up is complete. The urine samples will then be sent as a single batch to the Department of Infectious Disease, University of Maryland. Urines will be assayed in a blinded fashion and a written report of the levels of each of the 3 urine markers will be sent to Beaumont Hospital. Change in urine marker levels will be analyzed and correlated with change in symptom scores.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Interstitial Cystitis

Eligibility

Sex: FEMALEMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients will be drawn from Dr. Peters patient base that covers Southeast Michigan. Exclusion Criteria: * Male

Locations (1)

Beaumont Hospital - Royal Oak

Royal Oak, Michigan, United States

Outcomes

Primary Outcomes

The purpose of this study is measure urine biomarkers levels in patients with interstitial cystitis who have elected to undergo sacral nerve stimulation as a treatment modality for their disease.

Time frame: 1 year

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.